Skyepharma (SKP)
Summary
Sector: Pharmaceuticals & Biotechnology
Indices: FTSE Fledgling | techMARK 100 | techMARK
Currency: UK Pounds
| Bid Price: | 145p | Volume: | 32,575 |
| Mid Price: | 150p | Market Cap: | 32.70m |
| Offer Price: | 150p | 52 Wk High/Low: | 1,474.90p / 114.99p |
| Prev Close Price: | 147.5p | Shares in Issue: | 22m |
| Change Today: |  2.5p (1.67%) | Updated: | 16:18 |
Skyepharma: Company Overview
Skyepharma is a drug research and development company with a leading drug deliveries technology business, specialising in oral, topical, inhalable and injectable delivery systems.
Latest Announcements from Skyepharma
| 19/11/2008 | 16:36 | Price Monitoring Extension |
| 17/11/2008 | 18:04 | Share Purchase Plan |
| 14/11/2008 | 16:44 | Director/PDMR Shareholding |
| 30/10/2008 | 16:28 | Director Declaration |
| 27/10/2008 | 07:00 | Interim Management Statement |
Latest News featuring Skyepharma
| 27/10/2008 | 13:35 | TechMARK movers: Wolfson down on outlook |
| 27/10/2008 | 12:49 | SkyePharma says revenues showing growth |
| 23/10/2008 | 11:11 | TechMARK movers: Drug firms gain |
| 23/10/2008 | 09:14 | Skyepharma's Flutiform closer to US approval |
| 02/09/2008 | 16:25 | London close: Footsie stays ahead |
Latest Skyepharma Trades
| Date | Time | Buy/Sell | Price | Volume | Type (key) |
| 20/11/2008 | 16:18:50 | Sell | 150.00p | 3820 | Automatic Trade |
| 20/11/2008 | 16:03:52 | Sell | 150.00p | 1000 | Automatic Trade |
| 20/11/2008 | 16:03:09 | Sell | 151.00p | 1500 | Automatic Trade |
| 20/11/2008 | 16:01:09 | Buy | 150.00p | 2500 | Automatic Trade |
| 20/11/2008 | 15:09:43 | Buy | 150.00p | 2000 | Automatic Trade |
| 20/11/2008 | 15:09:12 | Sell | 148.00p | 1500 | Automatic Trade |
Latest Skyepharma Director Dealings
| Date | Notifier | Buy/Sell | Price | Volume |
Skyepharma Financial Overview
| Year End : | 31 December 2007 |
| Turnover : | £42m |
| Profit / Loss : | -£16m |
Skyepharma Key Personnel & Dates
| CEO: | Frank Condella |
| COO: | Ken Cunningham |
| Finance Director: | Peter Grant |
| Final Results: | n/a |
| Int. Results: | 28 August 2008 |
| AGM: | 21 May 2008 |
All data suppied by Digital Look (15 minute delay)
There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.
The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.